The DOI matches its Crossref record; 322 of the 322 references it cites were found in a registry or an index.
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Open accessAbstract
Tuberculosis (TB), one of the oldest known human diseases. is still is one of the major causes of mortality, since two million people die each year from this malady. TB has many manifestations, affecting bone, the central nervous system, and many other organ systems, but it is primarily a pulmonary disease that is initiated by the deposition of Mycobacterium tuberculosis, contained in aerosol droplets, onto lung alveolar surfaces. From this point, the progression of the disease can have several outcomes, determined largely by the response of the host immune system. The efficacy of this response is affected by intrinsic factors such as the genetics of the immune system as well as extrinsic factors, e.g., insults to the immune system and the nutritional and physiological state of the host. In addition, the pathogen may play a role in disease progression since some M. tuberculosis strains are reportedly more virulent than others, as defined by increased transmissibility as well as being associated with higher morbidity and mortality in infected individuals. Despite the widespread use of an attenuated live vaccine and several antibiotics, there is more TB than ever before, requiring new vaccines and drugs and more specific and rapid diagnostics. Researchers are utilizing information obtained from the complete sequence of the M. tuberculosis genome and from new genetic and physiological methods to identify targets in M. tuberculosis that will aid in the development of these sorely needed antitubercular agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“switching from aerobic respiration to various forms of anaerobic respiration to deal with low oxygen levels has been implicated as an important virulence attribute in several prokaryotic pathogens [18],[19]”
From A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus (2008) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Molecular Beacons: Probes that Fluoresce upon Hybridization
Tyagi, S., & Kramer, F. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-303 · Cited by 4,164
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A. M., Challis, G. L., Thomson, N. R., James, K., Harris, D. E., Quail, M. A., Kieser, H. M., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,226
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R. B., Armour, C. D., Bennett, H. A., Coffey, E. M., Dai, H. A., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,534
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
Hoiseth, S. K., & Stocker, B. A. D. (1981) · Nature · doi:10.1038/291238a0 · Cited by 2,088
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 2,045
Massive gene decay in the leprosy bacillus.
Cole, S. T., Eiglmeier, K., Parkhill, J., James, K. D., Thomson, N. R., Wheeler, P. R., Honoré, N., Garnier, T., Churcher, C., Harris, D., et al. (2001) · Nature · doi:10.1038/35059006 · Cited by 1,777
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R., Belisle, J. T., Bleharski, J. R., Maitland, M. L., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,659
A new evolutionary scenario for the Mycobacterium tuberculosis complex
Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P. M., Buchrieser, C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson, R. G., Kremer, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052548299 · Cited by 1,645
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,527
Research works printed but not linked: 14
- Butcher P. D. J. A. Mangan and I. M. Monahan. 1998. Intracellular gene expression p. 285-306. In T. Parish and N. G. Stoker (ed.) Mycobacterium tuberculosis protocols. Humana Press Totowa N.J.
- Derbyshire, K. M., C. Takacs, and J. Huang. 2000. Using the EZ:TNTMTransposomeTM for transposon mutagenesis in Mycobacterium smegmatis.Epicentre Forum7:1-4.
- Friedman L. N. (ed.). 2001. Tuberculosis: current concepts and treatment 2nd ed. CRC Press Inc. Boca Raton Fla.
- Garay. S. 1996. Pulmonary tuberculosis. p. 373-412. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
- Gomez M. and I. Smith. 2000. Determinants of mycobacterial gene expression p. 111-129. In G. F. Hatfull and W. R. Jacobs Jr (ed.) Molcular genetics of mycobacteria. American Society for Microbiology Washington. D.C.
- Haas F. and S. S. Haas. 1996. The origins of Mycobacterium tuberculosis and the notion of its contagiousness p. 3-19. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
- Hatfull G. F. and W. R. Jacobs Jr. (ed.). 2000. Molecular genetics of mycobacteria. American Society for Microbiology Washington D.C.
- Jagirdar J. and D. ZagZag. 1996. Pathology and insights into pathogenesis of tuberculosis p. 467-491. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
- Kamholz S. L. 1996. Pleural tuberculosis p. 483-491. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
- Munger J. S. and J. H. A. Chapman. 1996. Tissue destruction by proteases p. 353-361. In W. N. Rom and S. Garay (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
- Rom W. N. and S. Garay (ed.). 1996. Tuberculosis. Little Brown and Co. Boston Mass.
- Talavera W. R. Miranda K. Lessnau and L. Klapholz. 2001. Extrapulmonary tuberculosis p. 139-190. In L. N. Friedman (ed.) Tuberculosis: current concepts and treatment 2nd ed. CRC Press Inc. Boca Raton Fla.
- Tyagi A. K. S. K. D. Gupta and S. Jain. 2000. Gene expression: reporter technologies p. 131-147. In G. F. Hatfull and W. R. Jacobs Jr. (ed.) Molecular genetics of mycobacteria. American Society for Microbiology Washington D.C.
- Zugar A. and F. D. Lowy. 1996. Tuberculosis of the brain meninges and the spinal cord p. 541-556. In W. N. Rom and S. Gary (ed.) Tuberculosis. Little Brown and Co. Boston Mass.
Cited by
Sorted by citations
Items 301–400 of 1,000
Fu, L., & Fu-Liu, C. S. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-37 · Cited by 30
Rampini, S. K., Selchow, P., Keller, C., Ehlers, S., Böttger, E. C., & Sander, P. (2008) · Microbiology · doi:10.1099/mic.0.2008/018895-0 · Cited by 30
Promising role of microneedles in therapeutic and biomedical applications
Sil, D., Bhowmik, S., Patel, P., & Kurmi, B. D. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105273 · Cited by 29
Fekadu, G., Turi, E., Kasu, T., Bekele, F., Chelkeba, L., Tolossa, T., Labata, B. G., Dugassa, D., Fetensa, G., & Diriba, D. C. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.11.032 · Cited by 30
Maladan, Y., Krismawati, H., Wahyuni, T., Tanjung, R., Awaludin, K., Audah, K. A., & Parikesit, A. A. (2021) · BMC Genomics · doi:10.1186/s12864-021-08139-3 · Cited by 29
2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis
Naik, M., Ghorpade, S. R., Jena, L. K., Gorai, G., Narayan, A., Guptha, S., Sharma, S., Dinesh, N., Kaur, P., Nandishaiah, R., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5001933 · Cited by 29
Rodrigues, M. F., Alves, C. C. D. S., Figueiredo, B. B. M., Rezende, A. B., Wohlres-Viana, S., da Silva, V. L., Machado, M. A., & Teixeira, H. C. (2013) · Immunology · doi:10.1111/imm.12097 · Cited by 29
Hegde, S. R., Rajasingh, H., Das, C., Mande, S. S., & Mande, S. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033893 · Cited by 29
Mutation and virulence assessment of chromosomal genes of Rhodococcus equi 103.
Pei, Y., Parreira, V. R., Nicholson, V. M., & Prescott, J. F. (2007) · Europe PMC (PubMed Central) · Cited by 29
Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015)
Shay, J. W., Homma, N., Zhou, R., Naseer, M. I., Chaudhary, A. G., Al-Qahtani, M., Hirokawa, N., Goudarzi, M., Fornace, A. J., Baeesa, S. S., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-2858-0 · Cited by 32
Borrero, R., García, M. D. L. A., Canet, L., Zayas, C., Reyes, F., Prieto, J. L., Infante, J. F., Lanio, M. E., Kadir, R., López‐Hernández, Y., et al. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-s1-s13 · Cited by 28
Challenges of Tuberculosis in Iran
Bialvaei, A. Z., Asgharzadeh, M., Aghazadeh, M. H., Nourazarian, S. M., & Kafil, H. S. (2017) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.37866 · Cited by 28
Donini, S., Garavaglia, S., Ferraris, D. M., Miggiano, R., Mori, S., Shibayama, K., & Rizzi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175815 · Cited by 28
Pawar, A., Jha, P. K., Konwar, C., Chaudhry, U., Chopra, M., & Saluja, D. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9518-z · Cited by 28
Naik, P., Pandey, S., Gagan, S., Biswas, S., & Joseph, J. (2021) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-021-00268-w · Cited by 29
Belon, C., Gannoun-Zaki, L., Lutfalla, G., Kremer, L., & Blanc‐Potard, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116052 · Cited by 28
Mohanty, D., Sankaranarayanan, R., & Gokhale, R. S. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.04.006 · Cited by 28
Vairo, S., Broeck, W. V. D., Favoreel, H. W., Scagliarini, A., & Nauwynck, H. (2013) · Veterinary Research · doi:10.1186/1297-9716-44-22 · Cited by 28
Raff, J., Cook, D. C., & Kaestle, F. A. (2006) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762006001000005 · Cited by 28
Wagnew, F., Eshetie, S., Alebel, A., Dessie, G., Tesema, C., & Abajobir, A. A. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3390-x · Cited by 27
Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions
Al-Obaidi, H., Granger, A., Hibbard, T., & Opesanwo, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071056 · Cited by 27
A Review on Mycobacteriophages: From Classification to Applications
Hosseiniporgham, S., & Sechi, L. A. (2022) · Pathogens · doi:10.3390/pathogens11070777 · Cited by 27
Stevens, C. M., Babii, S. O., Pandya, A. N., Li, W., Li, Y., Mehla, J., Scott, R., Hegde, P. V., Prathipati, P. K., Acharya, A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113963119 · Cited by 27
Autophagy protects type II alveolar epithelial cells from Mycobacterium tuberculosis infection
Guo, X., Ji, T., Xia, Y., & Ma, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.111 · Cited by 27
Yu, H. S., Jeong, H. J., Hong, Y., Seol, S.-Y., Chung, D.-I., & Kong, H.-H. (2007) · Korean Journal of Parasitology · doi:10.3347/kjp.2007.45.1.11 · Cited by 27
Kocíncová, D., Sondén, B., Mendonça-Lima, L., Gicquel, B., & Reyrat, J. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00964-9 · Cited by 27
Surgical aspects of pulmonary tuberculosis: an update
Dewan, R. K., & Pezzella, A. T. (2016) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492316661958 · Cited by 26
Zanello, P. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.07.015 · Cited by 26
Tuberculosis increases the risk of peripheral arterial disease: A nationwide population‐based study
Wang, S., Chien, W., Chung, C., Lin, F., Peng, C., Chian, C., & Shen, C. (2017) · Respirology · doi:10.1111/resp.13117 · Cited by 26
Yadav, S., & Rawal, G. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.36.374.24260 · Cited by 26
Mani, N., Suresh, S., Govindammal, M., Kannan, S., Paulraj, E. I., Nicksonsebastin, D., & Prasath, M. (2023) · Chemical Physics Impact · doi:10.1016/j.chphi.2023.100254 · Cited by 26
Wang, Q., Zhu, L., Jones, V., Wang, C., Hua, Y., Shi, X., Feng, X., Jackson, M., Niu, C., & Gao, Q. (2015) · Infection and Immunity · doi:10.1128/iai.03081-14 · Cited by 26
Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa
Baker, J. L., Shriner, D., Bentley, A. R., & Rotimi, C. N. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.78 · Cited by 26
α-Pyrones and Their Hydroxylated Analogs as Promising Scaffolds Against Mycobacterium Tuberculosis
Bhat, Z. S., Rather, M. A., Syed, K. Y., & Ahmad, Z. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0116 · Cited by 26
Cueny, R. R., McMillan, S. D., & Keck, J. L. (2022) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2023.2181310 · Cited by 29
Parida, A., Mohanty, A., Kansara, B. T., & Behera, R. K. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b02894 · Cited by 25
Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues
Zuma, N. H., Smit, F. J., Seldon, R., Aucamp, J., Jordaan, A., Warner, D. F., & N’Da, D. D. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103587 · Cited by 25
Hailemariam, M., Yu, Y., Singh, H., Teklu, T., Wondale, B., Worku, A., Zewude, A., Mounaud, S. H., Tsitrin, T., Legesse, M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.595554 · Cited by 26
Candida glabrata is a successful pathogen: An artist manipulating the immune response
Castrejón-Jiménez, N. S., Castillo-Cruz, J., Baltierra‐Uribe, S. L., Hernández-González, J. C., & Estela, G.-P. B. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127038 · Cited by 35
Khan, A., Hunter, R. L., & Jagannath, C. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.09.019 · Cited by 25
Janardhan, S., Vivek, M. R., & Sastry, G. N. (2016) · Molecular BioSystems · doi:10.1039/c6mb00457a · Cited by 24
Zhang, X., Zhu, M., & Hu, X. (2018) · Epigenomics · doi:10.2217/epi-2018-0028 · Cited by 24
Maddali, N. K., Viswanath, I. V. K., Murthy, Y. L. N., Bera, R., Takhi, M., Rao, N. S., & Gudla, V. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02313-9 · Cited by 24
McGuire, M. K., Randall, A. Z., Seppo, A., Järvinen, K. M., Meehan, C. L., Gindola, D. K., Williams, J. E., Sellen, D., Kamau‐Mbuthia, E. W., Kamundia, E. W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614372 · Cited by 25
Mitra, K., Chadha, A., Muthuvijayan, V., & Doble, M. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01357 · Cited by 23
Shahrear, S., & Islam, A. B. M. M. K. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10515-4 · Cited by 24
Azide-Masked Fluorescence Turn-On Probe for Imaging Mycobacteria
Liyanage, S. H., Raviranga, N. G. H., Ryan, J., Shell, S. S., Ramström, O., Kalscheuer, R., & Yan, M. (2023) · JACS Au · doi:10.1021/jacsau.2c00449 · Cited by 24
Kaushal, S., Priyadarshi, N., Garg, P., Singhal, N. K., & Lim, D. (2023) · Nanomaterials · doi:10.3390/nano13182529 · Cited by 24
Zhou, X., Zhao, L., Liu, X., Li, X., Jia, F., Zhang, Y., & Wang, Y. (2011) · Phytotherapy Research · doi:10.1002/ptr.3536 · Cited by 24
Mycobacterium tuberculosis ftsH expression in response to stress and viability
Kiran, M., Chauhan, A., Dziedzic, R., Maloney, E., Mukherji, S. K., Madiraju, M. V. V. S., & Rajagopalan, M. R. (2009) · Tuberculosis · doi:10.1016/s1472-9792(09)70016-2 · Cited by 24
Chiranjeevi, B., Koyyada, G., Prabusreenivasan, S., Kumar, V., Sujitha, P., Kumar, C. G., Sridhar, B., Shaik, S., & Chandrasekharam, M. (2013) · RSC Advances · doi:10.1039/c3ra43345e · Cited by 24
Antimicrobial activity of extracts and phthalides occurring in Apiaceae plants
Pannek, J., Gach, J., Boratyński, F., & Olejniczak, T. (2018) · Phytotherapy Research · doi:10.1002/ptr.6098 · Cited by 24
Méndez‐Samperio, P., Pérez, A., & Torres, L. O. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.08.006 · Cited by 24
Experimental animal models of central nervous system tuberculosis: A historical review
Sánchez-Garibay, C., Hernández‐Campos, M. E., Tena‐Suck, M. L., & Salinas‐Lara, C. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.02.007 · Cited by 23
Dadhich, R., & Kapoor, S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00135-0 · Cited by 23
Lara-Espinosa, J. V., Arce-Aceves, M. F., López-Torres, M. O., Lozano-Ordaz, V., Mata‐Espinosa, D., Barrios‐Payán, J., Silva‐Islas, C. A., Maldonado, P. D., Marquina‐Castillo, B., & Hernández‐Pando, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041964 · Cited by 23
Verma, R. N., Malik, M. Z., Singh, G. P., & Subbarao, N. (2022) · Healthcare Analytics · doi:10.1016/j.health.2022.100052 · Cited by 23
Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant
Duong, V. T., Skwarczyński, M., & Tóth, I. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102307 · Cited by 24
Nucleoside Analogs and Tuberculosis: New Weapons Against an Old Enemy
Ferrari, V., & Serpi, M. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.166 · Cited by 23
Al-Dhabi, N. A., Esmail, G. A., Ghilan, A.-K. M., Arasu, M. V., & Duraipandiyan, V. (2019) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2019.12.021 · Cited by 23
Primary oral tuberculosis: a case series from Bucharest, Romania
Țovaru, Ș., Costache, M., & Sardella, A. (2008) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2008.01.027 · Cited by 23
Singh, V., & Somvanshi, P. (2008) · Journal of Molecular Modeling · doi:10.1007/s00894-008-0426-5 · Cited by 23
A Novel B-Cell Epitope Identified within Mycobacterium tuberculosis CFP10/ESAT-6 Protein
Yang, H., Chen, H., Liu, Z., Ma, H., Qin, L., Jin, R., Zheng, R., Feng, Y., Cui, Z., Wang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052848 · Cited by 22
Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis
Fatima, S., Kumari, A., Agarwal, M., Pahuja, I., Yadav, V., Dwivedi, V. P., & Bhaskar, A. (2021) · FEBS Journal · doi:10.1111/febs.16170 · Cited by 22
Shao, Z., Chow, M. Y. T., Chow, S. F., & Lam, J. K. W. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03488-y · Cited by 22
Ramsugit, S., & Pillay, M. (2016) · Europe PMC (PubMed Central) · Cited by 22
Somvanshi, P., Singh, V., & Seth, P. K. (2008) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000020 · Cited by 22
Diagnosis of mycobacterial skin infections
Kromer, C., Fabri, M., Schlapbach, C., Schulze, M. H., Groß, U., Schön, M. P., & Buhl, T. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13925 · Cited by 21
Medha, M., Priyanka, P., Bhatt, P., Sharma, S., & Sharma, M. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01778-1 · Cited by 21
Mycobacterium avium subspecies paratuberculosis
Li, L.-L., Singh, S. V., Bannantine, J. P., Kanjilal, S., & Kapur, V. (2008) · Springer eBooks · doi:10.1007/978-3-540-74042-1_2 · Cited by 21
Washburn, A., Abdeen, S. J., Ovechkina, Y., Ray, A., Stevens, M., Chitre, S., Sivinski, J., Park, Y., Johnson, J., Hoang, Q. Q., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.034 · Cited by 21
Bruce-Micah, R., Hüttenberger, D., Freitag, L., Cullum, J., & Foth, H. ‐. (2009) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2009.07.004 · Cited by 21
Bai, B., Xie, J., Yan, J., Wang, H., & Hu, C. (2006) · Drug Development Research · doi:10.1002/ddr.20152 · Cited by 21
Immune protection against tuberculosis – When is immunotherapy preferable to vaccination?
Grange, J. M., Brunet, L. R., & Rieder, H. L. (2011) · Tuberculosis · doi:10.1016/j.tube.2010.12.004 · Cited by 20
The pharmacological challenges of treating tuberculosis and HIV coinfections
Egelund, E. F., Dupree, L. H., Huesgen, E. C., & Peloquin, C. A. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1259066 · Cited by 20
Ufimtseva, E., Eremeeva, N. I., Petrunina, E. M., Umpeleva, T. V., Bayborodin, S. I., Vakhrusheva, D. V., & Skornyakov, S. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.07.001 · Cited by 20
Dreyer, V., Utpatel, C., Kohl, T. A., Barilar, I., Gröschel, M. I., Feuerriegel, S., & Niemann, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-64708-8 · Cited by 21
Salih, E. Y. A., Julkunen‐Tiitto, R., Luukkanen, O., Fahmi, M. K. M., & Fyhrquist, P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112264 · Cited by 20
Tuberculosis Vaccines: An Update of Recent and Ongoing Clinical Trials
Saramago, S., Magalhães, J., & Pinheiro, M. (2021) · Applied Sciences · doi:10.3390/app11199250 · Cited by 20
Nano-Drug Delivery Systems: Possible End to the Rising Threats of Tuberculosis
Sheikh, B. A., Bhat, B. A., Alshehri, B., Mir, R. A., Mir, W. R., Parry, Z. A., & Mir, M. A. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3201 · Cited by 20
Sharma, V., Hünnefeld, M., Luthe, T., & Frunzke, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-30829-z · Cited by 20
Tateishi, Y., Ozeki, Y., Nishiyama, A., Miki, M., Maekura, R., Kida, H., & Matsumoto, S. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02831-y · Cited by 20
Suman, S. K., Chandrasekaran, N., & Doss, C. G. P. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-23 · Cited by 21
Striking the Right Balance Determines TB or Not TB
Dasgupta, S. B., & Pieters, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00455 · Cited by 21
Environmental Risk Factors and Social Determinants of Pulmonary Tuberculosis in Pakistan
Khaliq, A., & Ih, K. (2015) · Epidemiology Open Access · doi:10.4172/2161-1165.1000201 · Cited by 20
Cui, J., Li, Z., Cui, K., Gao, Y., Zhang, B., Niu, J., & Wang, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107286 · Cited by 20
Doosti‐Irani, A., Shahraki, A. H., Ghaderi, E., Nasehi, M., & Mostafavi, E. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.01.020 · Cited by 20
Candidate Mycobacterium tuberculosis genes targeted by human microRNAs
Guo, W., Li, J.-T., Pan, X., Wei, L., & Wu, J. Y. (2010) · Protein & Cell · doi:10.1007/s13238-010-0056-4 · Cited by 20
Defining the Mandate of Tuberculosis Research in a Postgenomic Era
Chakhaiyar, P., & Hasnain, S. E. (2004) · Medical Principles and Practice · doi:10.1159/000078312 · Cited by 20
Kotlyarov, S. N., & Оськин, Д. Н. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062378 · Cited by 23
Application of antigenic biomarkers for Mycobacterium tuberculosis
Rodríguez-Hernández, E., Granados, L. I. Q., Flores‐Villalva, S., Cantó-Alarcón, J. G., & Milián-Suazo, F. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000325 · Cited by 18
Loci Associated With Antibody Response in Feral Swine (Sus scrofa) Infected With Brucella suis
Pierce, C. F., Brown, V. R., Olsen, S. C., Boggiatto, P. M., Pedersen, K., Miller, R. S., Speidel, S. E., & Smyser, T. J. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.554674 · Cited by 19
Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host
Ahmed, A. O. E., Ali, G. A. M., & Goravey, W. (2022) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2022_003249 · Cited by 19
Zheng, J., Liu, L., Wei, C., Leng, W., Yang, J., Li, W., Wang, J., & Jin, Q. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.09.010 · Cited by 19
Keerthirathne, T. P., Magana-Arachchi, D., Madegedara, D., & Sooriyapathirana, S. S. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1943-y · Cited by 19
Rajwani, R., Yam, W. C., Zhang, Y., Kang, Y., Wong, B. K. C., Leung, K. S. S., Tam, K. K.-G., Tafess, K., Zhu, L., & Siu, G. G. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00539 · Cited by 19
Integrated Multi-Omic Analysis of Mycobacterium tuberculosis H37Ra Redefines Virulence Attributes
Pinto, S. M., Verma, R., Advani, J., Chatterjee, O., Patil, A. H., Kapoor, S., Subbannayya, Y., Raja, R., Gandotra, S., & Prasad, T. S. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01314 · Cited by 19
Psychiatric Problems in Pulmonary Tuberculosis: Depression and Anxiety
Lara-Espinosa, J. V., & Hernández‐Pando, R. (2021) · Journal of Tuberculosis Research · doi:10.4236/jtr.2021.91003 · Cited by 19
Cubero, N., Esteban, J., Palenque, E., Rosell, A., & García, M. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03779.x · Cited by 19
Oiso, R., Fujiwara, N., Yamagami, H., Maeda, S., Matsumoto, S., Nakamura, S., Oshitani, N., Matsumoto, T., Arakawa, T., & Kobayashi, K. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2005.03.003 · Cited by 19
Metadata
- Authors
- Smith, I.
- Affiliations
- International Center for Public Health (US)
- Corresponding author
- Smith, Issar
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2003-07
- Volume
- 16
- Issue
- 3
- Pages
- 463-496
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC164219
- OpenAlex
- W2157638040
- Cited by
- 1,154
- References
- 322
- Citations by year
- 2026: 29 · 2025: 56 · 2024: 57 · 2023: 87 · 2022: 87 · 2021: 87 · 2020: 84 · 2019: 76 · 2018: 73 · 2017: 54 · 2016: 57 · 2015: 54 · 2014: 46 · 2013: 54 · 2012: 33
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01 HL 68513, R01HL064544, R01 HL 64544, R01HL068513)
- National Institute of Allergy and Infectious Diseases (R01 AI 48856, R01AI048856)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Mycobacterium tuberculosis, tuberculosis pathogenesis, bacterial virulence factors, host immune response, pulmonary tuberculosis, transmissibility, host genetics, host nutritional status, tuberculosis vaccine, tuberculosis drug targets, tuberculosis diagnosis
- MeSH terms
- Animals, Antitubercular Agents, Disease Models, Animal, Humans, Macrophages, Mycobacterium tuberculosis, Transcription, Genetic, Tuberculosis, Virulence, Genome, Bacterial, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review